MILLENNIUM MANAGEMENT LLC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$225,902
-24.6%
211,123
+82.6%
0.00%
Q2 2023$299,414
+10968.9%
115,604
-82.6%
0.00%
-100.0%
Q1 2023$2,705
+17.6%
662,966
+44.7%
0.00%
+100.0%
Q4 2022$2,300
-99.9%
458,230
+98.5%
0.00%
-50.0%
Q3 2022$3,019,000
-46.7%
230,846
-47.7%
0.00%
-50.0%
Q2 2022$5,660,000
-11.1%
441,475
+5.8%
0.00%
+33.3%
Q1 2022$6,366,000
-32.7%
417,416
-21.9%
0.00%
-40.0%
Q4 2021$9,463,000
+53.4%
534,349
+82.1%
0.01%
+66.7%
Q3 2021$6,168,000
+654.0%
293,442
+607.1%
0.00%
Q2 2021$818,000
+87.6%
41,501
+176.7%
0.00%
Q1 2021$436,000
-69.5%
15,000
-83.3%
0.00%
-100.0%
Q3 2020$1,429,000
+518.6%
89,803
+667.4%
0.00%
Q2 2020$231,000
-80.3%
11,703
-87.7%
0.00%
-100.0%
Q1 2020$1,172,000
-7.4%
95,082
+38.9%
0.00%
+50.0%
Q4 2019$1,265,000
+538.9%
68,435
+377.7%
0.00%
Q3 2019$198,000
-72.4%
14,327
-70.8%
0.00%
-100.0%
Q2 2019$718,00049,0160.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$79,175,00044.14%
Ponoi II Management, LLC 1,298,908$27,303,00040.46%
Column Group LLC 15,396,116$323,626,00036.81%
Ponoi Management, LLC 1,298,908$27,303,00024.24%
Euclidean Capital LLC 832,274$17,494,0008.50%
StepStone Group LP 1,573,357$33,072,0002.14%
Octagon Capital Advisors LP 200,000$4,204,0001.04%
Redmile Group, LLC 2,505,118$52,658,0000.92%
BVF INC/IL 955,000$20,074,0000.78%
Boxer Capital, LLC 500,000$10,510,0000.37%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders